Technology | May 13, 2014

Esaote Receives FDA Clearance for Virtual Navigator Ultrasound Fusion Imaging

Esaote FDA Clearance for Virtual Navigator Ultrasound Fusion Imaging MyLabTwice

May 13, 2014 — Esaote North America received U.S. Food and Drug Administration (FDA) clearance to market and sell its Virtual Navigator fusion imaging technology for ultrasound to U.S. customers.

Virtual Navigator provides the ability to fuse real-time ultrasound images with magnetic resonance imaging (MR), computed tomography (CT), positron emission tomography (PET) or 3-D ultrasound. Particularly useful for liver and other abdominal interventions, Virtual Navigator can also be used for gynecologic, musculoskeletal, obstetric, urologic, peripheral vascular and transcranial radiologic exams.

In use throughout Europe since 2002, Virtual Navigator is designed for easy integration into daily clinical practice and is available in the United States with a fully realized and robust feature set, including:

  • Fast Image Registration, using either single reference point or anatomical marker techniques
  • Intelligent Positioning, which acts like a GPS system to track movement of the probe as it is guided to the clinical target
  • Virtual Biopsy, which superimposes needle tracking on real-time images to help the operator during complex interventional procedures
  • Motion Sensor Technology, which automatically compensates for patient movement as it maintains image registration


“Virtual Navigator makes interventional procedures easier and safer,” said Brian Murphy, Esaote’s vice president of ultrasound marketing and sales. “Available in basic, advanced and extended versions, Virtual Navigator is a configurable and upgradable solution that enables institutions to purchase the capabilities they need today and upgrade as needs change in the future.”

Currently cleared for use with Esaote’s MyLabTwice system, the Virtual Navigator software option is intended to support a clinical radiological ultrasound exam and follow a percutaneous procedure by providing additional information from a second imaging modality.

Virtual Navigator works with a wide selection of transducers.

For more information: www.esaoteusa.com

Related Content

Hologic, Inc. announced he U.S. launch of the SuperSonic MACH 40 ultrasound system, expanding the company’s suite of ultrasound technologies with its first premium, cart-based system.
News | Breast Imaging | July 08, 2020
July 8, 2020 — Hologic, Inc. announced he U.S.
Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Fujifilm’s Sonosite SII POC ultrasound system helps to keep crowded areas clearer with a small ultrasound footprint.

Feature | Ultrasound Imaging | July 07, 2020 | By Joan Toth
With the miniaturization of technology, improved ease of use, lower system cost, increased portability and greater ac
A 3-D ultrasound system provides an effective, noninvasive way to estimate blood flow that retains its accuracy across different equipment, operators and facilities, according to a study published in the journal Radiology.

Volume flow as a function of color flow gain (at a single testing site). For each row the color flow c-plane and the computed volume flow are shown as a function of color flow gain. The c-plane is shown for four representative gain levels, whereas the computed volume flow is shown for 12–17 steps across the available gain settings. Flow was computed with (solid circles on the graphs) and without (hollow circles on the graphs) partial volume correction. Partial volume correction accounts for pixels that are only partially inside the lumen. Therefore, high gain (ie, blooming) does not result in overestimation of flow. Systems 1 and 2 converge to true flow after the lumen is filled with color pixel. System 3 is nearly constant regarding gain and underestimates the flow by approximately 17%. Shown are mean flow estimated from 20 volumes, and the error bars show standard deviation. Image courtesy of the journal Radiology

News | Ultrasound Imaging | July 01, 2020
July 1, 2020 — A 3-D ultrasound
In new QuickPoLL survey on imaging during the pandemic, responses were tallied from around 170 radiology administrators and business managers, who are part of an imagePRO panel created by The MarkeTech Group (TMTG), regarding the effects of COVID-19 on their business. TMTG is a research firm specializing in the medical device, healthcare and pharmaceutical industries.
Feature | Coronavirus (COVID-19) | June 30, 2020 | By Melinda Taschetta-Millane
Diffusion tractography uses the movement of water molecules to identify tracts that connect different parts of the brain. It can be used to pinpoint the part of the thalamus to treat with focused ultrasound. Image courtesy of UT Southwestern Medical Center

Diffusion tractography uses the movement of water molecules to identify tracts that connect different parts of the brain. It can be used to pinpoint the part of the thalamus to treat with focused ultrasound. Image courtesy of UT Southwestern Medical Center

News | Magnetic Resonance Imaging (MRI) | June 15, 2020
June 15, 2020 — Recently developed magneti...
 Samsung announced the immediate availability of the RS85 Prestige, the latest addition to the company’s portfolio of ultrasound systems.
News | Ultrasound Imaging | June 11, 2020
June 11, 2020 — Samsung announced the immediate availability of the ...